A carregar...

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation

BACKGROUND: Oral dabigatran was recently approved as an alternative to warfarin for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Unlike warfarin, dabigatran has a fixed dosage and few drug interactions, and does not require anticoagulation monitoring o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Choi, Jiyoon C, DiBonaventura, Marco d, Kopenhafer, Lewis, Nelson, Winnie W
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3923612/
https://ncbi.nlm.nih.gov/pubmed/24532967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S56187
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!